124 related articles for article (PubMed ID: 2806895)
1. [Analysis of the distribution of class I HLA-antigens in patients with systemic scleroderma with regard to features of the clinical course of the disease and therapy with D-penicillamine].
Pevnitskiĭ LA; Guseva NG; Sibiriakova LG; Oskilko TG
Genetika; 1989 Jun; 25(6):1101-7. PubMed ID: 2806895
[TBL] [Abstract][Full Text] [Related]
2. [HLA-A, B, C phenotype frequencies in progressive systemic scleroderma].
Baldauf C; Schaller J; Herrmann K; Haustein UF
Dermatol Monatsschr; 1989; 175(1):16-9. PubMed ID: 2920860
[TBL] [Abstract][Full Text] [Related]
3. HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea.
Kühnl P; Sibrowski W; Kalmar G; Holzmann H; Sollberg S; Böhm BO
Beitr Infusionsther; 1990; 26():287-9. PubMed ID: 1703854
[TBL] [Abstract][Full Text] [Related]
4. [Scleroderma and HLA antigens].
Holzmann H; Sollberg S; Schütz K; Kühnl P
Hautarzt; 1989 Mar; 40(3):134-40. PubMed ID: 2714991
[TBL] [Abstract][Full Text] [Related]
5. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
[TBL] [Abstract][Full Text] [Related]
6. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
Dequeker J; Van Wanghe P; Verdickt W
J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
[TBL] [Abstract][Full Text] [Related]
7. HLA antigens and primary osteoarthritis of the hand.
Merlotti D; Santacroce C; Gennari L; Geraci S; Acquafredda V; Conti T; Bargagli G; Canto ND; Biagi F; Gennari C; Giordano N
J Rheumatol; 2003 Jun; 30(6):1298-304. PubMed ID: 12784406
[TBL] [Abstract][Full Text] [Related]
8. Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo.
Misri R; Khopkar U; Shankarkumar U; Ghosh K
Indian J Dermatol Venereol Leprol; 2009; 75(6):583-7. PubMed ID: 19915238
[TBL] [Abstract][Full Text] [Related]
9. HLA-class I antigens in patients with unexplained recurrent abortion.
Imai T; Takakuwa K; Ishii K; Adachi H; Higashino M; Kurata H; Tanaka K
J Perinat Med; 2001; 29(5):427-32. PubMed ID: 11723844
[TBL] [Abstract][Full Text] [Related]
10. HLA class I antigens in families with coeliac disease.
Kedzierska A; Turowski G
Med Sci Monit; 2000; 6(5):957-63. PubMed ID: 11208438
[TBL] [Abstract][Full Text] [Related]
11. HLA-A, B, C antigens in pulmonary sarcoidosis in Polish population.
Dubaniewicz A; Szczerkowska Z
Arch Immunol Ther Exp (Warsz); 1999; 47(1):55-9. PubMed ID: 11729830
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
[TBL] [Abstract][Full Text] [Related]
13. [Detection of antigen specificities of HLA-A, B loci in perennial allergic rhinitis].
Lin S; Liu R; Guo H
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):18-20. PubMed ID: 10743120
[TBL] [Abstract][Full Text] [Related]
14. HLA class I phenotype and gene frequencies in parts of southern Nigeria.
Uko GP; Asuquo MA; Dawkins RL; Udim ER; Banjoko SO; Jaja O
Dis Markers; 1997 Apr; 13(2):123-9. PubMed ID: 9160188
[TBL] [Abstract][Full Text] [Related]
15. HLA markers for susceptibility and expression in scleroderma.
Gladman DD; Kung TN; Siannis F; Pellett F; Farewell VT; Lee P
J Rheumatol; 2005 Aug; 32(8):1481-7. PubMed ID: 16078323
[TBL] [Abstract][Full Text] [Related]
16. Association of HLA loci alleles and antigens in Saudi patients with vitiligo.
Abanmi A; Al Harthi F; Al Baqami R; Al Assaf S; Zouman A; Arfin M; Tariq M
Arch Dermatol Res; 2006 Dec; 298(7):347-52. PubMed ID: 17021767
[TBL] [Abstract][Full Text] [Related]
17. Paroxysmal nocturnal hemoglobinuria: significant association with specific HLA-A, -B, -C, and -DR alleles in an Italian population.
Lombardi ML; Terrazzano G; Cosentini E; Gargiulo L; Risitano A; Camerlingo R; Sica M; Aufiero D; Poggi A; Pirozzi G; Luzzatto L; Rotoli B; Notaro R; Alfinito F; Ruggiero G
Hum Immunol; 2008 Mar; 69(3):202-6. PubMed ID: 18396213
[TBL] [Abstract][Full Text] [Related]
18. Expression of A, B, C and DR antigens in definite Meniere's disease in a Spanish population.
López-Escámez JA; López-Nevot A; Cortes R; Ramal L; López-Nevot MA
Eur Arch Otorhinolaryngol; 2002 Aug; 259(7):347-50. PubMed ID: 12189399
[TBL] [Abstract][Full Text] [Related]
19. Influence of human leukocyte antigen in the pathogenesis of Ménière's disease in the South Korean population.
Yeo SW; Park SN; Jeon EJ; Lee HY; Pyo CW; Kim TG
Acta Otolaryngol; 2002 Dec; 122(8):851-6. PubMed ID: 12542204
[TBL] [Abstract][Full Text] [Related]
20. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
